The U.S. Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, preventing some patients from losing access to their telehealth-prescribed medications. The agencies…
Continue Reading
With less than three months before the clock runs out on telemedicine electronic prescribing flexibilities, Reps. Doris Matsui, D-California, and Earl “Buddy” Carter, R-Georgia, are leading a bipartisan charge to urge the U.S. Drug…
Continue Reading
Technology Leader Seeks to Help Tackle Growing Drug Diversion Challenge in the U.S.
Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug…
This past week, the U.S. Drug Enforcement Agency and the U.S. Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
The U.S. Drug Enforcement Agency (DEA) will extend telemedicine flexibilities around the prescription of certain controlled medications as it considers stakeholder feedback on proposed rules for post-COVID remote prescribing guardrails. The DEA received over…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
